A survey of stereotactic radiation therapy in veterinary medicine. Issue 6 (30th July 2018)

• Record Type: Journal Article
• Authors: Dunfield, Elizabeth M.; Turek, Michelle M.; Buhr, Kevin A.; Christensen, Neil C.
• Is Part Of: Veterinary radiology & ultrasound. Volume 59:Issue 6(2018)
• Page Start: 786
• Page End: 795
• Publication Date: 2018-07-30
• Subjects: hypofractionated -- intensity‐modulated -- oncology -- radiosurgery -- radiotherapy; Veterinary radiology -- Periodicals; Radiologie vétérinaire -- Périodiques; Échographie vétérinaire -- Périodiques; Radiography -- Periodicals; Ultrasonography -- Periodicals; Diagnosis -- Periodicals; Veterinary Medicine -- Periodicals; Societies, Medical -- Periodicals; 636.089607
• DOI: 10.1111/vru.12671
• Languages: English
• ISSNs: 1058-8183

Abstract

Abstract: Radiotherapy plays an important role in curative and palliative cancer treatment. As a novel radiation delivery technique, stereotactic radiotherapy utilizes three‐dimensional‐conformal treatment planning, high‐precision beam delivery technology, and patient specific position verification to target tumors, often in one to five high‐dose fractions. Currently, there is no consensus about best stereotactic radiotherapy practices in veterinary radiotherapy. The objective of this study was to document the breadth of perspectives, techniques, and applications of stereotactic radiotherapy in veterinary medicine. We conducted an online survey of American College of Veterinary Radiology members specializing in radiation oncology to assess how, when, and why stereotactic radiotherapy is being used. Both stereotactic radiotherapy users and nonusers completed the survey. The overall response and survey completion rates were 54% (67/123) and 87% (58/67), respectively. Overall, 55% of respondents reported providing stereotactic radiotherapy at their facility, with a median of 4.5 canine cases and one feline case per month. Delivery methods included C‐arm linear accelerator with multi‐leaf collimator, helical tomotherapy, and CyberKnife. Nonpituitary intracranial tumors, pituitary tumors, and sinonasal tumors were the most common cancers treated using stereotactic radiotherapy in both species. The most common fractionation scheme was three fractions of 10 Gy/fraction. The results of this survey suggest common availability of stereotactic radiotherapy in veterinary radiation facilities. These results provide valuable information regarding current stereotactic radiotherapy practices in veterinary medicine, and may provide an initial step toward standardizing methods and establishing consensus guidelines.